|
MechanismAT1R antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date09 Sep 2010 |
100 Clinical Results associated with Boryung Holdings Co., Ltd.
0 Patents (Medical) associated with Boryung Holdings Co., Ltd.
100 Deals associated with Boryung Holdings Co., Ltd.
100 Translational Medicine associated with Boryung Holdings Co., Ltd.